Incorporation of protein in PLG-microspheres with retention of bioactivity

被引:80
作者
Sturesson, C [1 ]
Carlfors, J [1 ]
机构
[1] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden
关键词
protein delivery; PLG microspheres; entrapment efficiency; bioactivity; stabilising additives;
D O I
10.1016/S0168-3659(00)00205-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The enzyme urease was incorporated into poly(lactide-co-glycolide) microspheres using a double emulsion solvent removal technique. Ethyl acetate was used as organic solvent since it is less toxic than the more commonly used methylene chloride. The effect of the two solvents on urease was compared. Although this preparation technique is well established, it is often associated with reduced bioactivity and low entrapment efficiency of proteins. In order to retain a high degree of bioactivity, the well known protein stabilisers: sucrose, trehalose and poloxamer 407, were added to the urease in the preparation. The bioactivity of the entrapped urease was reduced more by methylene chloride than by ethyl acetate. The gelled form of poloxamer was shown to highly favour the retention of bioactivity, demonstrated by an increase of 41% compared to preparations without poloxamer. Moreover, the presence of poloxamer strongly increased the in vitro release rate of urease from the microspheres. The entrapment efficiency was increased by 44% using the sugars in the preparation. These results clearly show the great potential of small quantities of additive in the formulation to control the properties of the microspheres. The amount and type of additive could be adjusted according to the therapeutic application of the preparation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 23 条
[1]  
BANGA AK, 1995, THERAPEUTIC PEPTIDES, P131
[2]   SOLVENT SELECTION IN THE PREPARATION OF POLY(DL-LACTIDE) MICROSPHERES PREPARED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) :179-186
[3]   A ONE-WEEK SUBDERMAL DELIVERY SYSTEM FOR L-METHADONE BASED ON BIODEGRADABLE MICROCAPSULES [J].
CHA, Y ;
PITT, CG .
JOURNAL OF CONTROLLED RELEASE, 1988, 7 (01) :69-78
[4]  
CLELAND JL, 1994, AIDS RES HUM RETROV, V10, pS21
[5]   QUALITY IMPROVEMENT OF SPRAY-DRIED, PROTEIN-LOADED D,L-PLA MICROSPHERES BY APPROPRIATE POLYMER-SOLVENT SELECTION [J].
GANDER, B ;
WEHRLI, E ;
ALDER, R ;
MERKLE, HP .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (01) :83-97
[6]   Biological activity of lysozyme after entrapment in poly (d,l-lactide-co-glycolide)-microspheres [J].
Ghaderi, R ;
Carlfors, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (11) :1556-1562
[7]   Effect of preparative parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres made by the double emulsion method [J].
Ghaderi, R ;
Sturesson, C ;
Carlfors, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 141 (1-2) :205-216
[8]   BIODEGRADABLE POLYMER SYSTEMS FOR THE SUSTAINED-RELEASE OF POLYPEPTIDES [J].
HUTCHINSON, FG ;
FURR, BJA .
JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) :279-294
[9]   INCREASED STABILIZING EFFECTS OF AMPHIPHILIC EXCIPIENTS ON FREEZE-DRYING OF LACTATE-DEHYDROGENASE (LDH) BY DISPERSION INTO SUGAR MATRICES [J].
IZUTSU, K ;
YOSHIOKA, S ;
KOJIMA, S .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :838-843
[10]   Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives [J].
Johansen, P ;
Men, Y ;
Audran, R ;
Corradin, G ;
Merkle, HP ;
Gander, B .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1103-1110